A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) (Estriol in MS)

This study has been completed.
Washington University School of Medicine
University of Texas Southwestern Medical Center
Ohio State University
University of Medicine and Dentistry of New Jersey
University of Chicago
Western Institute for Biomedical Research, Salt Lake City, UT
Johns Hopkins University
University of Kansas Medical Center
University of Minnesota - Clinical and Translational Science Institute
Mayo Clinic
University of Colorado, Aurora
University of New Mexico
University of Pennsylvania
Dartmouth Medical School, Lebanon, NH
National Multiple Sclerosis Society
National Institutes of Health (NIH)
Synthetic Biologics, Ann Arnor, MI
Information provided by (Responsible Party):
Rhonda Voskuhl, University of California, Los Angeles
ClinicalTrials.gov Identifier:
First received: March 22, 2007
Last updated: December 18, 2014
Last verified: December 2014